Abstract
This research service provides a strategic analysis of biochips markets within
the United States. The market was divided into the total U.S. DNA microarray
markets, total U.S. proteomics arrays markets, and total U.S. microfluidics/
lab-on-a-chip markets segments.
Each segment covers market trends, technology trends, competitive structure,
market share analysis, and revenue forecasts. The key challenges and
strategies are covered for the total market overview.